News

age-related macular degeneration
Correlation between cardiovascular risk and risk of developing eye diseases found
Recent study results highlight the association between an individual's cardiovascular risk score and their odds of developing certain eye diseases.

diabetic macular edema
Eydenzelt receives FDA approval for four retinal diseases
Eydenzelt is approved for use in treating wet age-related macular degeneration, macular edema following reetinal vein occlusion, diabetic macular edema and diabetic retinopathy.

diabetic retinopathy
Diabetic retinopathy risk doubled for diabetic patients who have psoriasis
The research team at the Taipei Veterans General Hospital reviewed data from the global TriNetX network to evaluate whether the inflammatory skin condition, psoriasis, impacts eye health in people ...

chronic kidney disease
Severity of Diabetic Retinopathy Impacts heart failure risk for those with Chronic Kidney Disease
A recent study highlights the relationship between the severity of diabetic retinopathy and the risk of heart failure for patients who also have chronic kidney disease.

diabetic macular edema
Vitamin D deficiency linked to diabetic maculopathy
Researchers recently sought to determine the role vitamin D plays in the development of diabetic macular ischemia (DMI), which is an irreversible diabetic maculopathy.

cataract surgery
Risk of diabetic retinopathy progression linked to cataract surgery
Health record data was evaluated by researchers looking for the potential risk of diabetic retinopathy progression following non-complex cataract surgery.

diabetic macular edema
Regeneron receives FDA approval for EYLEA HD
The Food and Drug Administraton (FDA) gave approval after two active-controlled, double-masked pivotal trials, which compared EYLEA HD to EYLEA over a 48 week period.

cataract surgery
5 Ways Vision is Affected by Diabetes
It's critical that diabetic patients understand how the disease could affect the eyes.

diabetic macular edema
Experimental drug shows promise in preventing diabetic retinal vascular diseases
An experimental drug that had previously demonstrated an ability to slow the growth of liver tumors in mice, has now shown an ability to prevent diabetic retinal vascular disease.
